These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. Hill WD, Arai M, Cohen JA, Trojanowski JQ. J Comp Neurol; 1993 Mar 15; 329(3):328-36. PubMed ID: 8459049 [Abstract] [Full Text] [Related]
13. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A. Brain; 2009 Feb 15; 132(Pt 2):319-35. PubMed ID: 19039008 [Abstract] [Full Text] [Related]
14. [Biochemical bases of Parkinson disease]. Colucci d'Amato C, Puccini A, Cristillo A, Vizioli R. Recenti Prog Med; 1984 Oct 15; 75(10):889-901. PubMed ID: 6151219 [No Abstract] [Full Text] [Related]
15. The metabolism of orally administered L-dopa in Parkinson patients. Cote LJ, Cohen G, Yahr MD. Trans Am Neurol Assoc; 1971 Oct 15; 96():222-3. PubMed ID: 5159086 [No Abstract] [Full Text] [Related]
16. [Medical treatment of Parkinson's disease]. Castaigne P, Rondot P, Ribadeau-Dumas JL. Ann Med Interne (Paris); 1972 Apr 15; 123(4):357-64. PubMed ID: 5077040 [No Abstract] [Full Text] [Related]
17. [Biochemistry of the extrapyramidal system--from anatomical viewpoint]. Sano Y, Murase Y. Shinkei Kenkyu No Shimpo; 1968 Dec 15; 12(4):859-68. PubMed ID: 4898006 [No Abstract] [Full Text] [Related]